A recent double-blind, placebo-controlled human clinical study found that Promentum Recover, a formulation of calcium fructoborate, turmeric extract, and pomegranate extract manufactured by Futureceuticals, delivered statistically significant benefits to measures of exercise recovery over placebo.

The study, conducted at Loughborough University, tested the formula in a population of 24 healthy adults (14 men and 10 women) after a strenuous bout of muscle-damaging exercise.

Participants who used Promentum Recover had a reduction in self-reported muscle pain scores of 17% compared to placebo, 72 hours following the exercise.

Promentum Recover significantly improved scores in a questionnaire, such as self-reported exercise-induced exhaustion, with individuals feeling more recovered throughout the 72-hour post-exercise period, indicating a faster return to readiness after training.

Participants also reported feeling less mentally drained and experienced better sleep quality following the exercise. The researchers noted that there is a connection between strenuous exercise and sleep disruption, which can complicate and delay recovery.

The 300 mg dose used in the trial is “markedly lower” than typical turmeric and pomegranate extracts used to achieve recovery benefits, the authors said.

“This study marks the first published clinical investigation of our marquis ingredient, calcium fructoborate, in an exercise recovery context, expanding our wide body of existing research on the patented mineral complex into the sports nutrition market with newly added benefits,” said J. Randal Wexler, vice president of R&D and general counsel at FutureCeuticals. “These recovery benefits are a natural complement to our long history of clinical and commercial success in the joint and mobility space.”